ArticleInfection and drug resistance2020

Clinical Efficacy and Cost-Effectiveness of β-Lactam/β-Lactamase Inhibitor Combinations and Carbapenems in Liver Cirrhosis Patients with Gram-Negative Bacteria Bloodstream Infection.

Yuzhu Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.